Sales de-grew by 7.98%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)
Zim Laboratories Share Price
Zim Laboratories Share Price
Zim Laboratories share price insights
Stock gave a 3 year return of 142.84% as compared to Nifty Smallcap 100 which gave a return of 79.29%. (as of last trading session)
Company has spent 1.88% of its operating revenues towards interest expenses and 14.52% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Stock generated 142.84% return as compared to Nifty Pharma which gave investors 62.04% return over 3 year time period. (as of last trading session)
Zim Laboratories Ltd. share price moved down by -0.41% from its previous close of Rs 115.95. Zim Laboratories Ltd. stock last traded price is 115.48
Share Price Value Today/Current/Last 115.48 Previous Day 115.95
Key Metrics
PE Ratio (x) | 31.40 | ||||||||||
EPS - TTM (₹) | 3.68 | ||||||||||
MCap (₹ Cr.) | 564.98 | ||||||||||
Sectoral MCap Rank | 83 | ||||||||||
PB Ratio (x) | 2.37 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| - | ||||||||||
VWAP (₹) | 116.19 | ||||||||||
52W H/L (₹) |
Zim Laboratories Share Price Returns
1 Day | -0.41% |
1 Week | -2.25% |
1 Month | 5.58% |
3 Months | 12.89% |
1 Year | -2.05% |
3 Years | N.A. |
5 Years | N.A. |
Zim Laboratories News & Analysis
Small the “New Big” on D-St as retail holding value in Indian firms up 3x since Covid lows
NewsShare market update: Most active stocks of the day in terms of total traded value
NewsStock market update: Stocks that hit 52-week lows on NSE in today's trade
NewsCompliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcements
Zim Laboratories Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Zim Laboratories Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Topline Contraction
Sales de-grew by 7.98%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent 1.88% of its operating revenues towards interest expenses and 14.52% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 82.82 119.40 97.40 87.25 68.56 Total Income Growth (%) -30.63 22.58 11.64 27.26 -35.39 Total Expenses 78.73 106.12 88.69 80.59 66.64 Total Expenses Growth (%) -25.81 19.65 10.06 20.93 -29.77 EBIT 4.09 13.28 8.71 6.66 1.92 EBIT Growth (%) -69.17 52.43 30.78 246.96 -82.88 Profit after Tax (PAT) 0.90 8.09 4.78 4.15 0.23 PAT Growth (%) -88.89 68.99 15.31 1,731.20 -96.87 EBIT Margin (%) 4.94 11.12 8.94 7.63 2.80 Net Profit Margin (%) 1.08 6.77 4.91 4.76 0.33 Basic EPS (₹) 0.18 1.66 0.98 0.85 0.05 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 446.82 341.58 341.63 324.78 325.30 Total Assets Growth (%) 30.81 -0.01 5.19 -0.16 -0.96 Total Liabilities 208.08 141.23 165.92 164.03 171.48 Total Liabilities Growth (%) 47.33 -14.88 1.15 -4.34 -3.30 Total Equity 238.75 200.35 175.71 160.75 153.82 Total Equity Growth (%) 19.17 14.02 9.31 4.50 1.79 Current Ratio (x) 1.43 1.72 1.45 1.35 1.27 Total Debt to Equity (x) 0.45 0.30 0.29 0.41 0.50 Contingent Liabilities 19.44 31.54 7.91 7.09 7.90 All figures in Rs Cr, unless mentioned otherwise
Insights
Aggressive Profit Recognition
Over last 5 years, operating cash flow has been continuously falling as compared to company's net profit. (Source: Consolidated Financials)Increase in Cash from Investing
Company has used Rs 73.01 cr for investing activities which is an YoY increase of 101.67%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 16.28 37.52 49.21 31.85 21.92 Net Cash used in Investing Activities -73.01 -36.20 -14.57 -5.88 -19.06 Net Cash flow from Financing Activities 59.53 0.55 -32.97 -25.97 -2.51 Net Cash Flow 3.18 3.00 2.03 -0.07 0.96 Closing Cash & Cash Equivalent 9.60 6.42 3.42 1.39 1.46 Closing Cash & Cash Equivalent Growth (%) 49.52 87.72 145.62 -4.69 192.73 Total Debt/ CFO (x) 6.53 1.59 1.04 2.09 3.52 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 7.22 12.19 8.28 4.55 2.14 Return on Capital Employed (%) 10.63 17.73 14.99 14.39 6.99 Return on Assets (%) 3.85 7.15 4.25 2.25 1.01 Interest Coverage Ratio (x) 6.72 10.47 5.46 2.41 1.01 Asset Turnover Ratio (x) 0.93 1.17 1.00 94.60 85.37 Price to Earnings (x) 27.03 14.45 17.86 16.10 27.47 Price to Book (x) 1.95 1.76 1.48 0.73 0.59 EV/EBITDA (x) 12.06 6.93 6.74 4.18 6.03 EBITDA Margin (%) 12.66 14.65 13.61 13.70 9.76
Zim Laboratories Peer Comparison
Zim Laboratories Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 142.84% as compared to Nifty Smallcap 100 which gave a return of 79.29%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 142.84% return as compared to Nifty Pharma which gave investors 62.04% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 142.84% as compared to Nifty Smallcap 100 which gave a return of 79.29%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 142.84% return as compared to Nifty Pharma which gave investors 62.04% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Zim Laboratories Board Meeting/AGM
Zim Laboratories Dividends
- Others
Meeting Date Announced on Purpose Details Aug 03, 2024 Jul 29, 2024 Board Meeting Quarterly Results May 13, 2024 May 07, 2024 Board Meeting Audited Results Jan 30, 2024 Dec 29, 2023 POM - Jan 29, 2024 Jan 23, 2024 Board Meeting Quarterly Results Nov 01, 2023 Oct 23, 2023 Board Meeting Quarterly Results Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 5% 0.5 Sep 19, 2019 May 22, 2019 Final 10% 1.0 Sep 03, 2018 Aug 14, 2018 All Types Ex-Date Record Date Announced on Details Bonus Dec 22, 2022 Dec 22, 2022 Nov 12, 2022 Bonus Ratio: 2 share(s) for every 1 shares held Bonus Oct 04, 2018 Oct 06, 2018 Aug 14, 2018 Bonus Ratio: 1 share(s) for every 1 shares held
About Zim Laboratories
Zim Laboratories Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 562.69 Crore) operating in Pharmaceuticals sector. Zim Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Export Incentives for the year ending 31-Mar-2024. Show More
Executives
Auditors
- AD
Anwar Daud
Chairman & Managing DirectorKMKakasaheb Mahadik
Independent DirectorKSKamlesh Shende
Independent DirectorKLKavita Loya
Independent DirectorShow More - Walker Chandiok & Co. LLP
Industry
Key Indices Listed on
-
Address
Sadoday Gyan (Ground Floor),Opp. NADT, Nelson Square,Nagpur, Maharashtra - 440013
More Details
FAQs about Zim Laboratories share
- 1. What is Zim Laboratories share price and what are the returns for Zim Laboratories share?Zim Laboratories share price was Rs 115.48 as on 13 Sep, 2024, 03:59 PM IST. Zim Laboratories share price was down by 0.41% based on previous share price of Rs 117.34. Zim Laboratories share price trend:
- Last 1 Month: Zim Laboratories share price moved up by 5.58%
- Last 3 Months: Zim Laboratories share price moved up by 12.89%
- Last 12 Months: Zim Laboratories share price moved down 2.05%
- Last 3 Years: Zim Laboratories Share price moved remain unchanged by N.A.
- 2. What are the Zim Laboratories quarterly results?Total Revenue and Earning for Zim Laboratories for the year ending 2024-03-31 was Rs 372.61 Cr and Rs 17.25 Cr on Consolidated basis. Last Quarter 2024-06-30, Zim Laboratories reported an income of Rs 82.82 Cr and profit of Rs 0.90 Cr.
- 3. What are the returns for Zim Laboratories share?Return Performance of Zim Laboratories Shares:
- 1 Week: Zim Laboratories share price moved down by 2.25%
- 1 Month: Zim Laboratories share price moved up by 5.58%
- 3 Month: Zim Laboratories share price moved up by 12.89%
- 6 Month: Zim Laboratories share price moved up by 22.53%
- 4. What is the PE & PB ratio of Zim Laboratories?The PE ratio of Zim Laboratories stands at 31.53, while the PB ratio is 2.37.
- 5. Which are the key peers to Zim Laboratories?Top 10 Peers for Zim Laboratories are Medicamen Biotech Ltd., Kilitch Drugs(I) Ltd., SMS Lifesciences India Ltd., Lyka Labs Ltd., Venus Remedies Ltd., Medico Remedies Ltd., Wanbury Ltd., Brooks Laboratories Ltd., Vaishali Pharma Ltd. and Ind-Swift Laboratories Ltd.
- 6. What are the key metrics to analyse Zim Laboratories Share Price?Key Metrics for Zim Laboratories are:
- PE Ratio of Zim Laboratories is 31.40
- Price/Sales ratio of Zim Laboratories is 1.27
- Price to Book ratio of Zim Laboratories is 2.37
- 7. Who's the owner of Zim Laboratories?
- Promoter holding has not changed in last 9 months and holds 33.26 stake as on 30 Jun 2024
- Foreign Institutional Investors holding has not changed in last 9 months and holds 0.0 stake as on 30 Jun 2024
- Other investor holding has not changed in last 9 months and holds 66.74 stake as on 30 Jun 2024
- 8. What's the market capitalization of Zim Laboratories?Within the Pharmaceuticals sector, Zim Laboratories stock has a market cap rank of 83. Zim Laboratories has a market cap of Rs 564.98 Cr.
- 9. What dividend is Zim Laboratories giving?An equity Final dividend of Rs 0.5 per share was declared by Zim Laboratories Ltd. on 22 May 2019. So, company has declared a dividend of 5% on face value of Rs 10 per share. The ex dividend date was 19 Sep 2019.
- 10. What is the CAGR of Zim Laboratories?The CAGR of Zim Laboratories is 4.57.
- 11. What is Zim Laboratories's 52 week high / low?In last 52 weeks Zim Laboratories share had a high price of Rs 131.40 and low price of Rs 89.50
- 12. Who's the chairman of Zim Laboratories?Anwar Daud is the Chairman & Managing Director of Zim Laboratories
Trending in Markets
Zim Laboratories Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.